Versigent (NYSE:VGNT) Director Sells $3,385,517.10 in Stock

Versigent (NYSE:VGNT) Director Kevin Clark sold 74,130 shares of the stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total value of $3,385,517.10. Following the completion of the sale, the director owned 124,849 shares in the company, valued at approximately $5,701,853.83. The trade was a 37.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Versigent Price Performance

Shares of NYSE:VGNT traded up $0.71 on Thursday, hitting $46.45. 470,596 shares of the company’s stock were exchanged, compared to its average volume of 1,777,686. Versigent has a 12 month low of $26.34 and a 12 month high of $50.88. The company has a market capitalization of $3.29 billion and a PE ratio of 24.19. The stock’s 50 day simple moving average is $44.16. The company has a debt-to-equity ratio of 7.29, a current ratio of 1.40 and a quick ratio of 1.09.

Versigent (NYSE:VGNT) last issued its earnings results on Tuesday, August 4th. The company reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.34. The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Equities analysts forecast that Versigent will post 7.23 EPS for the current fiscal year.

Versigent Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Friday, September 4th will be given a $0.13 dividend. This represents a $0.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, September 4th.

Analyst Ratings Changes

A number of equities analysts have commented on VGNT shares. UBS Group dropped their target price on shares of Versigent from $58.00 to $55.00 and set a “buy” rating on the stock in a research note on Thursday, July 9th. Zacks Research lowered Versigent from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Weiss Ratings initiated coverage on Versigent in a research note on Wednesday, August 5th. They issued a “hold (c)” rating on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $54.00 price objective on shares of Versigent in a report on Wednesday, August 5th. Finally, Argus lifted their target price on Versigent from $50.00 to $54.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $54.00.

Institutional Investors Weigh In On Versigent

Several large investors have recently modified their holdings of VGNT. Integrated Wealth Concepts LLC purchased a new stake in shares of Versigent in the 2nd quarter worth approximately $57,000. Sequoia Financial Advisors LLC purchased a new position in Versigent during the second quarter valued at approximately $220,000. Kintegral Advisory LLC bought a new position in Versigent in the second quarter worth approximately $224,000. Engineers Gate Manager LP bought a new position in Versigent in the second quarter worth approximately $418,000. Finally, Corient Private Wealth LP bought a new position in Versigent in the second quarter worth approximately $426,000.

Versigent Company Profile

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.